by matthew | Mar 19, 2025 | 2025, Featured Product Reports, Featured Reports Home, Product Reports
Collecting Plasma in the US: Ecosystem Analysis, Cost Benchmarking & Forecast to 2034 Announcement COLLECTING PLASMA IN THE US:ECOSYSTEM ANALYSIS, COST BENCHMARKING & FORECAST TO 2034 INTRODUCTION Over the past decade, US source plasma collections...
by matthew | Oct 24, 2024 | 2024, Featured Product Reports, Featured Reports Home, Product Reports
Global Immunoglobulin (IG) Usage in 2023 & Forecast to 2030 AN ANALYSIS OF THE GLOBAL IMMUNOGLOBULIN (IG) MARKET IN 2023AND FORECAST TO THE YEAR 2030 by country. As immunoglobulin (IG) is the dominant revenue-generating therapeutic protein from plasma...
by matthew | Apr 3, 2024 | 2024, Featured Product Reports, Featured Reports Home, Product Reports
Global Forecast of Hemophilia A and B Therapies by Product, Region and Company to 2030 The Global Forecast of the Hemophilia A and B Therapies by Region, Product Category and Company to 2030 is a quantitative projection of the sales of all the coagulation...
by matthew | Oct 4, 2023 | 2023, Featured Product Reports, Featured Reports Home, Product Reports
The Global Market for Non-Therapeutic Albumin in 2022 and Forecast to 2030 While therapeutic applications make up the bulk of the human albumin market, there are significant niche markets for non-therapeutic applications (NTAs) of albumin across a variety of...
by matthew | May 11, 2023 | 2023, Featured Product Reports, Featured Regional Reports, Featured Reports Home, Product Reports, Regional Reports
Global Blood & Plasma Collection and Use — 2021/2022 Announcement The demand and need for more plasma has never been higher. Since 2020, the availability of plasma, and where it is located around the world, has become even more relevant than in...
by matthew | Apr 12, 2023 | 2023, Featured Product Reports, Featured Reports Home, Product Reports
Mammalian (CHO) Clinical GMP Manufacturing and Support Activity Cost Analysis 2020-2022 The demand and need for therapeutic proteins, monoclonal antibodies, vaccines, and industrial enzymes has never been higher. This growing demand for biologics has led to an...
